New AAV serotypes may broaden the therapeutic pipeline to human gene therapy.
Williams
David A
DA
D000818:Animals; D000229:Dependovirus / Q000145:classification / Q000235:genetics* / Q000276:immunology; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D005822:Genetic Vectors; D006801:Humans; D007113:Immunity, Innate; D051379:Mice; D011323:Primates / Q000821:virology; D012703:Serotyping; D000515:alpha 1-Antitrypsin / Q000235:genetics* / Q000378:metabolism
D000515:alpha 1-Antitrypsin